Timothy L. Wyant

Person

Bellingham, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Conjoint therapies for immunomodulation
- Patent number 12,064,418
- Issue date Aug 20, 2024
- Curis, Inc.
- Pottayil Govindan N. Sasikumar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Engineered anti-IL-2 antibodies
- Patent number 11,851,485
- Issue date Dec 26, 2023
- AULOS BIOSCIENCE, INC.
- Inbar Amit
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Predicting outcome of treatment with an anti-α4β7 integrin antibody
- Patent number 11,596,688
- Issue date Mar 7, 2023
- Takeda Pharmaceutical Company Limited
- Maria Rosario
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Conjoint therapies for immunomodulation
- Patent number 11,497,735
- Issue date Nov 15, 2022
- Aurigene Discovery Technologies Limited
- Pottayil Govindan N. Sasikumar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
METHODS OF USE OF ANTI-IL-2 ANTIBODIES
- Publication number 20240287169
- Publication date Aug 29, 2024
- Aulos Bioscience, Inc
- James VASSELLI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF USE OF ANTI-IL-2 ANTIBODIES
- Publication number 20240279329
- Publication date Aug 22, 2024
- Aulos Bioscience, Inc
- James Robert VASSELLI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PREDICTING OUTCOME OF TREATMENT WITH AN ANTl-alpha4beta7 INTEGRIN A...
- Publication number 20240173402
- Publication date May 30, 2024
- Takeda Pharmaceutical Company Limited
- Maria ROSARIO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ENGINEERED ANTI-IL-2 ANTIBODIES
- Publication number 20240092888
- Publication date Mar 21, 2024
- Aulos Bioscience, Inc
- Inbar AMIT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENGINEERED ANTI-IL-2 ANTIBODIES
- Publication number 20230203152
- Publication date Jun 29, 2023
- Aulos Bioscience, Inc
- Inbar AMIT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-TUMOR NECROSIS FACTOR RECEPTOR (TNFR2) ANTIBODIES AND USES THE...
- Publication number 20230167188
- Publication date Jun 1, 2023
- Biolojic Design Ltd.
- Inbar AMIT
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CONJOINT THERAPIES FOR IMMUNOMODULATION
- Publication number 20230081191
- Publication date Mar 16, 2023
- AURIGENE DISCOVERY TECHNOLOGIES LIMITED
- Pottayil Govindan N. Sasikumar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENGINEERED ANTI-IL-2 ANTIBODIES
- Publication number 20230085471
- Publication date Mar 16, 2023
- Aulos Bioscience, Inc
- Inbar AMIT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CONJOINT THERAPIES FOR IMMUNOMODULATION
- Publication number 20200289477
- Publication date Sep 17, 2020
- AURIGENE DISCOVERY TECHNOLOGIES LIMITED
- Pottayil Govindan N. Sasikumar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PREDICTING OUTCOME OF TREATMENT WITH AN ANTI-alpha4beta7 INTEGRIN A...
- Publication number 20200155673
- Publication date May 21, 2020
- Millennium Pharmaceuticals, Inc.
- Maria Rosario
- G01 - MEASURING TESTING
Information Patent Application
PREDICTING OUTCOME OF TREATMENT WITH AN ANTI-alpha4beta7 INTEGRIN A...
- Publication number 20170360926
- Publication date Dec 21, 2017
- Millennium Pharmaceuticals, Inc.
- Maria Rosario
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Timothy L. Wyant

Person

Patents Grantslast 30 patents

Conjoint therapies for immunomodulation

Engineered anti-IL-2 antibodies

Predicting outcome of treatment with an anti-α4β7 integrin antibody

Conjoint therapies for immunomodulation

Patents Applicationslast 30 patents

METHODS OF USE OF ANTI-IL-2 ANTIBODIES

METHODS OF USE OF ANTI-IL-2 ANTIBODIES

PREDICTING OUTCOME OF TREATMENT WITH AN ANTl-alpha4beta7 INTEGRIN A...

ENGINEERED ANTI-IL-2 ANTIBODIES

ENGINEERED ANTI-IL-2 ANTIBODIES

ANTI-TUMOR NECROSIS FACTOR RECEPTOR (TNFR2) ANTIBODIES AND USES THE...

CONJOINT THERAPIES FOR IMMUNOMODULATION

ENGINEERED ANTI-IL-2 ANTIBODIES

CONJOINT THERAPIES FOR IMMUNOMODULATION

PREDICTING OUTCOME OF TREATMENT WITH AN ANTI-alpha4beta7 INTEGRIN A...

PREDICTING OUTCOME OF TREATMENT WITH AN ANTI-alpha4beta7 INTEGRIN A...